中国实用眼科杂志
中國實用眼科雜誌
중국실용안과잡지
CHINESE JOURNAL OF PRACTICAL OPHTHALMOLOGY
2012年
8期
912-916
,共5页
李保江%高晓唯%李文静%胡裕坤%杨磊%练海东
李保江%高曉唯%李文靜%鬍裕坤%楊磊%練海東
리보강%고효유%리문정%호유곤%양뢰%련해동
有晶状体眼%后房型人工晶状体%高度近视
有晶狀體眼%後房型人工晶狀體%高度近視
유정상체안%후방형인공정상체%고도근시
Phakic%Posterior chamber intraocular lens%Myopia
目的 评价有晶状体眼后房型人工晶状体植入术治疗高度近视的有效性、安全性及稳定性.方法 后房型人工晶状体植入术治疗高度近视患者26例(40只眼),随访术前及术后1天、1周及1、6、12个月,随访内容包括裸眼视力、最佳矫正视力、屈光度数、裂隙灯显微镜检查、眼压、角膜内皮计数、Pentacam、光学相干断层成像等,观察屈光状态及术后并发症.结果 所有手术均顺利进行,所有患者裸眼视力均有明显提高,40只眼术前裸眼视力和最好矫正视力分别为0.05+0.02,0.61+0.28;术后分别提高为0.62±0.17,0.62±0.31,术后裸眼视力均明显好于术前(P<0.05).术前平均屈光度为(-18.95±4.73)D,术后1个月平均屈光度为(-0.76±0.75)D.术前角膜内皮细胞数(2917.42+208.36)个/mm2,术后1个月角膜内皮细胞为(2797.03+ 210.25)个/mm2.术前平均眼压为(16.65±4.75) mm Hg,术后第一天眼压为(15.47±4.36) mm Hg.通过Pentacam观察术前前房深度(3.25+0.27) mm,而术后1月复查减少到(2.97+0.19) mm,两者相比较差异具有统计学意义(P<0.05),而以后随访中前房深度没有明显差异.40只眼均未发生瞳孔阻滞性青光眼、晶状体前囊下混浊等并发症.结论 有晶状体眼后房型人工晶状体植入术对高度近视的治疗是一种有效的方法,具有有效性、稳定性及矫正效果好等优点,但需要有更长时间的随访.
目的 評價有晶狀體眼後房型人工晶狀體植入術治療高度近視的有效性、安全性及穩定性.方法 後房型人工晶狀體植入術治療高度近視患者26例(40隻眼),隨訪術前及術後1天、1週及1、6、12箇月,隨訪內容包括裸眼視力、最佳矯正視力、屈光度數、裂隙燈顯微鏡檢查、眼壓、角膜內皮計數、Pentacam、光學相榦斷層成像等,觀察屈光狀態及術後併髮癥.結果 所有手術均順利進行,所有患者裸眼視力均有明顯提高,40隻眼術前裸眼視力和最好矯正視力分彆為0.05+0.02,0.61+0.28;術後分彆提高為0.62±0.17,0.62±0.31,術後裸眼視力均明顯好于術前(P<0.05).術前平均屈光度為(-18.95±4.73)D,術後1箇月平均屈光度為(-0.76±0.75)D.術前角膜內皮細胞數(2917.42+208.36)箇/mm2,術後1箇月角膜內皮細胞為(2797.03+ 210.25)箇/mm2.術前平均眼壓為(16.65±4.75) mm Hg,術後第一天眼壓為(15.47±4.36) mm Hg.通過Pentacam觀察術前前房深度(3.25+0.27) mm,而術後1月複查減少到(2.97+0.19) mm,兩者相比較差異具有統計學意義(P<0.05),而以後隨訪中前房深度沒有明顯差異.40隻眼均未髮生瞳孔阻滯性青光眼、晶狀體前囊下混濁等併髮癥.結論 有晶狀體眼後房型人工晶狀體植入術對高度近視的治療是一種有效的方法,具有有效性、穩定性及矯正效果好等優點,但需要有更長時間的隨訪.
목적 평개유정상체안후방형인공정상체식입술치료고도근시적유효성、안전성급은정성.방법 후방형인공정상체식입술치료고도근시환자26례(40지안),수방술전급술후1천、1주급1、6、12개월,수방내용포괄라안시력、최가교정시력、굴광도수、렬극등현미경검사、안압、각막내피계수、Pentacam、광학상간단층성상등,관찰굴광상태급술후병발증.결과 소유수술균순리진행,소유환자라안시력균유명현제고,40지안술전라안시력화최호교정시력분별위0.05+0.02,0.61+0.28;술후분별제고위0.62±0.17,0.62±0.31,술후라안시력균명현호우술전(P<0.05).술전평균굴광도위(-18.95±4.73)D,술후1개월평균굴광도위(-0.76±0.75)D.술전각막내피세포수(2917.42+208.36)개/mm2,술후1개월각막내피세포위(2797.03+ 210.25)개/mm2.술전평균안압위(16.65±4.75) mm Hg,술후제일천안압위(15.47±4.36) mm Hg.통과Pentacam관찰술전전방심도(3.25+0.27) mm,이술후1월복사감소도(2.97+0.19) mm,량자상비교차이구유통계학의의(P<0.05),이이후수방중전방심도몰유명현차이.40지안균미발생동공조체성청광안、정상체전낭하혼탁등병발증.결론 유정상체안후방형인공정상체식입술대고도근시적치료시일충유효적방법,구유유효성、은정성급교정효과호등우점,단수요유경장시간적수방.
Objective To evaluate the efficacy and safety of the surgical correction of high myopia using a phakic posterior chamber intraocular lens. Methods Forty eyes of 26 patients with high myopia who accepted surgery treatment.Each eye was examined before and after surgery one day,one week,one month,six months and twelve months.The examination included visual acuity,refraction,tonometry, Pentacam, anterior chamber depth,horizontal corneal diameter (white to white),and posterior segment evaluation after indirect ophthalmolscope examination. Results All eyes of preoperative uncorrected visual acuity and best-corrected visual acuity (BCVA) were 0.05+0.02,0.61+0.28 respectively and postoperative were 0.62±0.17,0.62±0.31 respectively.The mean preoperative SE was (-18.95±4.73)D and postoperative SE was (-1.50±0.75)D.The mean preoperative ECD was (2917.42+208.36)/mm2 and postoperative ECD was (2797.03+210.25)/mm2.The mean preoperative IOP was (16.65±4.75)mmHg and postoperative IOP at first day was (15.47±4.36)mmHg.Pentacam showed that preoperative ACD was (3.25+0.27)mm and postoperative ACD reduced to (2.97+0.19)mm. Conclusions The phakic IOLs is an effective treatment for the correction of high myopia and has significant advantages such as reversibility,immediate correction,stability,and relative simplicity.However,long-term studies are necessary to assess the potential risks.